All Pharma News
KSQ Therapeutics and CTMC Announce Strategic Collaboration

KSQ Therapeutics and CTMC Announce Strategic Collaboration
BUSINESSWIRE
06 Sep 2023
Share Share
Roche inks KSQ deal to expand stable of synthetic lethal assets

Roche inks KSQ deal to expand stable of synthetic lethal assets
Nick Paul Taylor FIERCE BIOTECH
13 Jul 2023
Share Share
Takeda puts $510M on the line to expand KSQ cancer collaboration

Takeda puts $510M on the line to expand KSQ cancer collaboration
Nick Paul Taylor FIERCE BIOTECH
18 May 2023
Share Share
Japan`s Ono signs up for KSQ`s preclinical cancer programs

Japan`s Ono signs up for KSQ`s preclinical cancer programs
BUSINESSWIRE
26 Jan 2023
Share Share
KSQ Appoints Mahesh Karande to its Board of Directors

KSQ Appoints Mahesh Karande to its Board of Directors
BUSINESSWIRE
08 Dec 2022
Share Share
KSQ Announces First Patient Dosed in Combination Portion of PI Study of KSQ-4279

KSQ Announces First Patient Dosed in Combination Portion of PI Study of KSQ-4279
BUSINESSWIRE
07 Dec 2022
Share Share
KSQ Therapeutics Announces Leadership and Board Additions

KSQ Therapeutics Announces Leadership and Board Additions
BUSINESSWIRE
23 Sep 2022
Share Share
KSQ Tx to Present Data at the AACR 2022 Annual Meeting

KSQ Tx to Present Data at the AACR 2022 Annual Meeting
BUSINESSWIRE
22 Mar 2022
Share Share
KSQ Therapeutics Doses First Patient in PI Study of KSQ-4279 in Solid Tumors

KSQ Therapeutics Doses First Patient in PI Study of KSQ-4279 in Solid Tumors
BUSINESSWIRE
14 Sep 2021
Share Share
Takeda eyes pathway to natural killer therapies, teeing up $100M to partner KSQ

Takeda eyes pathway to natural killer therapies, teeing up $100M to partner KSQ
C. Mitchell ENDPTS
14 Jan 2021
Share Share